S&P 500 7,551.81 −0.45%
Nasdaq 25,978.42 −0.01%
S&P/TSX 35,491.27 −0.26%
Apple 332.41 +0.32%
Nvidia 213.90 +0.82%
Microsoft 490.30 −1.37%
Shopify 181.77 +0.54%
Royal Bank 283.06 −0.40%
CAD/USD 0.7148 −0.47%
PRE-MKT · 08:20 ET
Market ClerkRecap
Thu Sep 17 · pre-market3 signals today312 insider buys this week · $295.5MCIRO short report next: Sep 30The week ahead

PBYI

PUMA BIOTECHNOLOGY, INC.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
9.39
+0.14 +1.51%
USD · Sep 17, 08:20 a.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $484.7MP/E 18.1DIV YIELD FCF YIELD 8.49%REV TTM $231.2M −2.9%NET INCOME $26.7M −44.9%NET CASH $25.2M52W 4.34 – 9.69SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names PBYI.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch PBYI. Know when insiders buy.
One email the day a filing lands. Free.